BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23647131)

  • 1. Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.
    Jordán J; Ruíz-Moreno JM
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1181-92. PubMed ID: 23647131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier.
    Hosoya K; Tomi M; Tachikawa M
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1571-87. PubMed ID: 22035231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.
    Mannermaa E; Vellonen KS; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1136-63. PubMed ID: 17081648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of blood-ocular barrier transporters in retinal drug disposition: an overview.
    Tomi M; Hosoya K
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1111-24. PubMed ID: 20438316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in drug and nutrient transport across the blood-retinal barrier.
    Kubo Y; Akanuma SI; Hosoya KI
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):513-531. PubMed ID: 29719158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the posterior segment of the eye.
    Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
    Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood-retinal barrier: structure and functional significance.
    Runkle EA; Antonetti DA
    Methods Mol Biol; 2011; 686():133-48. PubMed ID: 21082369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, activity and pharmacokinetic impact of ocular transporters.
    Vellonen KS; Hellinen L; Mannermaa E; Ruponen M; Urtti A; Kidron H
    Adv Drug Deliv Rev; 2018 Feb; 126():3-22. PubMed ID: 29248478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal drug delivery in retinal disease: are we out of our depth?
    Thakur SS; Barnett NL; Donaldson MJ; Parekh HS
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1575-90. PubMed ID: 24931577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influx Transport of Cationic Drug at the Blood-Retinal Barrier: Impact on the Retinal Delivery of Neuroprotectants.
    Kubo Y; Akanuma SI; Hosoya KI
    Biol Pharm Bull; 2017; 40(8):1139-1145. PubMed ID: 28768994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation.
    Ramsay E; Hagström M; Vellonen KS; Boman S; Toropainen E; Del Amo EM; Kidron H; Urtti A; Ruponen M
    Eur J Pharm Biopharm; 2019 Oct; 143():18-23. PubMed ID: 31419586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery to the retina: challenges and opportunities.
    Duvvuri S; Majumdar S; Mitra AK
    Expert Opin Biol Ther; 2003 Feb; 3(1):45-56. PubMed ID: 12718730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inner blood-retinal barrier: molecular structure and transport biology.
    Hosoya K; Tachikawa M
    Adv Exp Med Biol; 2012; 763():85-104. PubMed ID: 23397620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier].
    Kubo Y
    Yakugaku Zasshi; 2015; 135(10):1135-40. PubMed ID: 26423869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability of ocular vessels and transport across the blood-retinal-barrier.
    Törnquist P; Alm A; Bill A
    Eye (Lond); 1990; 4 ( Pt 2)():303-9. PubMed ID: 2199237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport barriers in transscleral drug delivery for retinal diseases.
    Kim SH; Lutz RJ; Wang NS; Robinson MR
    Ophthalmic Res; 2007; 39(5):244-54. PubMed ID: 17851264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen attenuates VEGF-initiated blood-retina barrier breakdown in male rats.
    Chen X; Zhang M; Jiang C; Guo W; Liu H; Wei S
    Horm Metab Res; 2011 Aug; 43(9):614-8. PubMed ID: 21823056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of lipid nanoparticles to ocular drug delivery.
    Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of Drug Transporters in Blood-Retinal Barrier.
    Liu L; Liu X
    Adv Exp Med Biol; 2019; 1141():467-504. PubMed ID: 31571172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of membrane permeability evaluated in in vitro analyses to estimate blood-retinal barrier permeability.
    Kubo Y; Fukui E; Akanuma S; Tachikawa M; Hosoya K
    J Pharm Sci; 2012 Jul; 101(7):2596-605. PubMed ID: 22535532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.